SQZ Biotechnologies Co·4

Jan 26, 4:48 PM ET

Capasso Richard 4

4 · SQZ Biotechnologies Co · Filed Jan 26, 2023

Insider Transaction Report

Form 4
Period: 2023-01-24
Capasso Richard
See Remarks
Transactions
  • Award

    Stock Option

    2023-01-24+213,000213,000 total
    Exercise: $0.73Exp: 2033-01-24Common Stock (213,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 25% of the underlying securities on January 24, 2024 and in 36 substantially equal monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION